Researchers at MIT developed a device that monitors heart rate, breathing, and other vital signs from within a patient’s GI tract. The device is potentially useful for detecting respiratory depression during an opioid overdose. Since conventional sleep studies require multiple sensors and devices to be connected to the patient, the MIT device will be especially beneficial for sleep studies. The device, tested in humans for the first time during a trial, transmits data through a wireless antenna and has two small batteries. The study showed that the ingestible sensor was able to measure health metrics as effectively as traditional diagnostic equipment. Importantly, there were no adverse effects associated with capsule ingestion. In the future, the device could be utilized to administer drugs such as nalmefene to reverse an overdose if breathing rate slows or stops. Further data from the studies will be released later.
Related Posts
Elon Musk Ordered to Testify in SEC’s Twitter Investigation
- admin
- December 15, 2023
- 0
Elon Musk’s attempts to avoid further testifying for the Twitter-takeover investigation have hit a roadblock. In a San Francisco hearing, a federal judge rejected Musk’s […]
The Official Arrival of Microsoft’s Copilot AI on Windows 10
- admin
- November 16, 2023
- 0
Microsoft is bringing Copilot AI to Windows 10 for Windows Insider users in an upcoming Release Preview update, where Copilot will appear on the right […]
Federal Trade Commission Faces Lawsuit from Meta to Halt Implementation of New Regulations on Profiting from Children’s Data
- admin
- November 30, 2023
- 0
Meta is suing the Federal Trade Commission (FTC) to prevent the reopening of a $5 billion privacy settlement from 2020 and to allow it to […]
